Singapore markets close in 24 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.64-0.21 (-2.37%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
16,788,000
16,887,000
18,854,000
22,385,000
21,903,000
Cost of revenue
9,176,000
9,351,000
10,558,000
11,560,000
10,044,000
Gross profit
7,614,000
7,537,000
8,296,000
10,825,000
11,859,000
Operating expenses
Research development
919,000
1,010,000
1,213,000
1,848,000
2,111,000
Selling general and administrative
3,681,000
3,806,000
4,214,000
4,986,000
5,096,000
Total operating expenses
4,571,000
4,794,000
5,407,000
6,812,000
7,207,000
Operating income or loss
3,043,000
2,743,000
2,889,000
4,013,000
4,652,000
Interest expense
904,000
881,000
920,000
875,000
546,000
Total other income/expenses net
-2,553,000
-3,130,000
-4,500,000
-21,520,000
-3,280,000
Income before tax
-415,000
-1,265,000
-2,596,000
-18,379,000
824,000
Income tax expense
-271,000
-278,000
-195,000
-1,933,000
521,000
Income from continuing operations
-153,000
-1,000,000
-2,472,000
-16,449,000
311,000
Net income
4,000
-999,000
-2,150,000
-16,265,000
329,000
Net income available to common shareholders
4,000
-999,000
-2,399,000
-16,525,000
68,000
Basic EPS
-
-0.91
-2.35
-16.26
0.07
Diluted EPS
-
-0.91
-2.35
-16.26
0.07
Basic average shares
-
1,091,000
1,021,000
1,016,000
955,000
Diluted average shares
-
1,091,000
1,021,000
1,016,000
961,000
EBITDA
-
1,338,000
166,000
-15,392,000
2,894,000